skip to content »

Pathology

Houston, Texas

Department of Pathology
Pathology
not shown on screen

Faculty

Thomas M. Wheeler, M.D. Professor and Chair

photoAlt

Education

  • M.D.

Residency

  • Resident, Baylor College of Medicine, 1977-1981

  • Chief Resident, Baylor College of Medicine, 1980-1981

Specialty

  • Pathology

Board Certification

  • American Board of Pathology, Anatomic and Clinical, 1981

  • American Board of Pathology, Cytopathology, 1990

  • American Board of Pathology, Anatomic and Clinical, Voluntary Recertification, 1998

Current Position

  • Chairman, Department of Pathology, Baylor College of Medicine, Houston, Texas, 2004-present

Professional Positions Held

  • Harlan J. Spjut, M.D. Professor of Pathology, 2001-present

  • Associate Chairman, Department of Pathology, Baylor College of Medicine, Houston, Texas, 1995-present

  • Professor of Pathology & Urology, Baylor College of Medicine, Houston, Texas, 1995-present

Honors and Awards

  • Alpha Chi Honor Society

  • American Institute of Chemists Award (outstanding senior student in Chemistry)

  • Outstanding alumnus, 1997

  • Alpha Omega Alpha, 1976--present

  • Stuart A. Wallace Award (outstanding student in Pathology), 1976

  • Award for excellence in Physiology, 1975

  • Voted by peers to be included in listing of The Best Doctors in America, 1998-2005

  • Herbert Lansky Award, College of American Pathologists, 1999

  • Life Member of the National Registry of Who's Who, 2001

  • Voted by peers to be included in listing of America's Top Doctors, 2001-2005

Membership on professional organizations

  • Alpha Omega Alpha

  • American Board of Pathology, Anatomic Pathology Test Committee, 1995-99

  • American Association for Cancer Research

  • American Foundation for Thyroid Patients, Medical Advisory Board, 1998-1999

  • American Medical Association

  • American Society for Clinical Pathology

  • American Society of Cytopathology

  • American Society of Investigative Pathology

  • American Thyroid Association

  • American Urological Association

  • Association of Pathology Chairs

  • College of American Pathologists:
    State Advisory Committee, 1994-97
    Chairman, 1999-2000
    Delegate to House of Delegates, 1993-2003
    Government Affairs Committee, 1996-2003
    Council on Government and Professional Affairs, 1999-2003
    Nominating Committee 2000
    Chair, 2001, 2005-2006
    Education Committee 2004-present
    Council on Scientific Affairs, 2004-present
    Chair, 2005-2006
    Board of Governors, 2003-2006
    Executive Committee, 2005-present
    Chair, Ad Hoc Work Group for Pathology Report Standardization, 2006-present

  • Harris County Medical Society

  • Houston Society of Clinical Pathologists:
    President, 1992
    Scientific Seminar Chair 1988, 2001

  • International Society of Urological Pathology

  • Texas Society of Cytology, President, 1988

  • Texas Society of Pathologists:
    Alternate Delegate, 1993-1995
    Delegate 1995-present
    Secretary 1997
    President-Elect 1998
    President 1999
    Chair Nominating Committee 2000

  • The Thyroid Society for Education and Research, Board of Directors, 1993-98

  • U.S. and Canadian Academy of Pathology, Abstract Review Board, 1997-2000, 2006-2009

Representative Publications

  1. Donohue JF, Bianco FJ Jr, Kuroiwa K, Vickers AJ, Wheeler TM, Scardino PT, Reuter VA, Eastham JA. Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading. J Urol. 2006 Sep;176(3):991-5
  2. Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res. 2006 Aug 15;12(16):4872-5
  3. Srigley JR, Amin MB, Epstein JI, Grignon DJ, Humphrey PA, Renshaw AA, Wheeler TM; Members of the Cancer Committee, College of American Pathologists. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland. Arch Pathol Lab Med. 2006 Jul;130(7):936-46
  4. Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol. 2006 Jun;37(6):726-34
  5. Ayala GE, Dai H, Tahir SA, Li R, Timme T, Ittmann M, Frolov A, Wheeler TM, Rowley D, Thompson TC. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res. 2006 May 15;66(10):5159-64
  6. Ayala G, Satoh T, Li R, Shalev M, Gdor Y, Aguilar-Cordova E, Frolov A, Wheeler TM, Miles BJ, Rauen K, Teh BS, Butler EB, Thompson TC, Kadmon D. Biological response determinants in HSV-tk + Ganciclovir gene therapy for prostate cancer. Mol Ther. 2006 April;13(4):716-728
  7. Lopez-Corona E, Ohori M, Wheeler TM, Reuter VE, Scardino PT, Kattan MW, Eastham JA. Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate. J Urol. 2006 Mar;175(3 Pt 1):923-7; discussion 927-8
  8. Mims MP, Hayes TG, Zheng S, Leal SM, Frolov A, Ittmann MM, Wheeler TM, Prchal JT. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 2006 Feb 1;66(3):1880; author reply 1880-1
  9. Li R, Wheeler TM, Dai H, Sayeeduddin M, Scardino PT, Frolov A, Ayala GE. Biological correlates of p27 compartmental expression in prostate cancer. J Urol. 2006 Feb;175(2):528-32
  10. Ayala GE, Dai H, Li R, Ittmann M, Thompson TC, Rowley D, Wheeler TM. Bystin in perineural invasion of prostate cancer. Prostate. 2006 Feb 15;66(3):266-72
  11. Tetzlaff MT, Teh BS, Timme TL, Fujita T, Satoh T, Tabata K, Mai WY, Vlachaki MT, Amato RJ, Kadmon D, Miles BJ, Ayala G, Wheeler TM, Aguilar-Cordova E, Thompson TC and Butler EB. Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer. Technol Cancer Res Treat 5(1):23-26, 2006
  12. Malins DC, Gilman NK, Green VM, Wheeler TM, Barker EA, Anderson KA. A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis. PNAS. 2005 Dec; 102(52):19093-19096
  13. Anton RC, Wheeler TM. Frozen Section of Thyroid and Parathyroid Specimens. Arch Pathol Lab Med. 2005 Dec; 129(12):1575-1584
  14. Dai H, Li R, Wheeler T, Diaz de Vivar A, Frolov A, Tahir S, Agoulnik I, Thompson T, Rowley D, Ayala G. Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate. 2005 Nov 1;65(3):276-86
  15. Haqq C, Li R, Khodabakhsh D, Frolov A, Ginzinger D, Thompson T, Wheeler T, Carroll P, Ayala G. Ethnic and racial differences in prostate stromal estrogen receptor alpha. Prostate. 2005 Oct 1;65(2):101-9